Cancer Pathogenesis and Therapy
Издатель: Elsevier · ISSN 2949-7132 · 37 статей
-
Kirsten rat sarcoma viral oncogene (KRAS) G12D and pan-RAS inhibitors in pancreatic ductal adenocarcinoma: clinical progress and strategies to overcome resistance
Publication date: Available online 19 November 2026 Source: Cancer Pathogenesis and Therapy Author(s): Xiang Li, Yiwen Chen, Xiaozhen Zhang, Xueli Bai
-
Genetically predicted inflammatory mediators link mitochondrial function to breast cancer risk: A Mendelian randomization study
Publication date: Available online 13 April 2026 Source: Cancer Pathogenesis and Therapy Author(s): Liuxin Ran, Jia Feng, Junyu Chen, Jiang Wang, Jinbo Liu, Xidan Zhu
-
Longitudinal assessment of biopsy-resection histological discordance in digestive tract epithelial neoplasms and development of a colorectal upgrading prediction model
Publication date: Available online 11 July 2026 Source: Cancer Pathogenesis and Therapy Author(s): Zhang Zhang, Yawei Bi, Yang Xiao, Xiaotong Niu, Nan Ru, Longsong Li, Haiyang Li, Jingyuan Xiang, Yan Wang, Ningli Chai
-
Low-incidence adverse events (AEs): An emerging challenge in chimeric antigen receptor T-cell (CAR-T) therapy
Publication date: Available online 28 July 2026 Source: Cancer Pathogenesis and Therapy Author(s): Bingxue Li, Keliang Cui
-
MicroRNA (miRNA) dysregulation in virus-associated cancers: From molecular mechanisms to therapeutic breakthroughs
Publication date: Available online 14 August 2026 Source: Cancer Pathogenesis and Therapy Author(s): Yusuf Saleem Khan, Aisha Farhana, Mohammed Kuddus, Mohd Adnan Kausar, Syed M.A. Shahid, Ghorashy E.Y. Mohammed, Abuzar Abdulwahab...
-
Mechanistic target of rapamycin complex (mTORC)-glutamine axis in cancer: Mechanistic crosstalk, therapeutic resistance, and clinical opportunities
Publication date: Available online 19 August 2026 Source: Cancer Pathogenesis and Therapy Author(s): Subha Ranjan Das, Igor Koman, Elimelech Nesher
-
Cover
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s):
-
Table of Contents
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s):
-
Moving cardio-oncology upstream: Integrating cardiovascular prevention into routine cancer care
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s): Meiyan Liu
-
Rewiring metabolic-immune circuitry in pancreatic ductal adenocarcinoma (PDAC)
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s): Xiaoyi Yin, Gang Jin
-
Advances in radiotherapy-based multimodal treatment for non-small-cell lung cancer
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s): Chenfei Wu, Ming Chen
-
Beyond chemotherapy: The rise of nucleic acid nanoformulations in personalized lung cancer therapy
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s): Sania Hermain, Harshitha K.S., Raghavendra Naveen Nimbagal
-
Cancer therapy-induced cardiotoxicity: mechanisms, biomarkers, psychological stress, and emerging therapeutic strategies
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s): Haiyang Chen, Lijun Zhang, Meiyan Liu, Yanwei Li, Peijun Rao
-
From fusion partner to clinical practice: A treatment-oriented framework for transcription factor E3 (TFE3)-rearranged renal cell carcinoma
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s): Jiangwei Man, Kangyu Wang, Yalong Zhang, Hao Wang, Li Yang
-
Mortality risk in patients with urological malignancies and human immunodeficiency virus (HIV) coinfection: A systematic review and meta-analysis of cohort studies
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s): Yihang Zhang, Fei Zhao, Defu Yuan, Yueyu Huang, Taiyi Jiang, Tong Zhang, Hao Wu, Yu Zhang, An Zhao, Zhiqiang Zhu, Bin Su
-
Efficacy and safety of SCT200 in patients with recurrent or metastatic head and neck squamous cell carcinoma after platinum failure: A phase 2 trial
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s): Yuankai Shi, Qingyuan Zhang, Wei Wang, Jianhua Shi, Xiaodong Zhu, Kunyu Yang, Lin Wang, Guoqing Li, Peiguo Wang, Lin Gui
-
Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s): Weijie Ma, Hongyuan Zhao, Reggie R. Fan, Chihong Zhou, Dingning Liu, Shuai Chen, Tianhong Li
-
An immune exhaustion signature predicts prognosis and identifies patients with diffuse large B-cell lymphoma (DLBCL) who derive preferential benefit from chimeric antigen receptor (CAR)-T cell therapy
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s): Bo Zheng, Wanqian Hu, Ying Fang, Rong Li
-
Call for Papers | Special Issue
Publication date: September 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 5 Author(s):
-
A classification-first pathway for reproductive and endocrine health after radiotherapy for skull-base-adjacent malignancies
Publication date: Available online 8 September 2026 Source: Cancer Pathogenesis and Therapy Author(s): Tianci Tang, Zhoushijia Zhai, Shunhui Sun, Yuantong Huang, Xiaqiu Wu, Fu Chen
-
DKK1-CKAP4 axis functions as an immunometabolic checkpoint linking tumor-intrinsic signaling with immune suppression
Publication date: Available online 11 September 2026 Source: Cancer Pathogenesis and Therapy Author(s): Markos Despotidis, Orestis Lyros, Tatiana S. Driva, Maria Theochari, Andreas Mamilos, Michalis V. Karamouzis, Stratigoula...
-
Divergent Melanoma Trajectories in the Western Pacific: Declining Mortality in Oceania and Diagnostic Challenges for Non-UV Subtypes in Asia
Publication date: Available online 16 September 2026 Source: Cancer Pathogenesis and Therapy Author(s): Yifan Ren, Bin Lyu, Jinxin Lan, Mingyu Li, Yinghui Lyu, Yongli Tian, Siting Wu, Jiacai Lin, Yaqi Ma
-
Cardiotoxicity of Novel Hemato-Oncology Therapies: Mechanisms, Monitoring, and Multidisciplinary Management
Publication date: Available online 17 September 2026 Source: Cancer Pathogenesis and Therapy Author(s): Evdokia Mandala, Thomas Achladas, Kyranna Lafara, Aikaterini Barmpouti, Vasiliki Koukoulitsa, Ioannis Kalafatis, Christos Lafaras
-
Tn-Associated Truncated O-linked N-acetylgalactosamine (O-GalNAc) Glycosylation in Pancreatic Cancer: Mechanisms, Biomarkers, and Therapeutic Translation
Publication date: Available online 14 October 2026 Source: Cancer Pathogenesis and Therapy Author(s): Shaoqian Zhang, Shaolong Hao, Xichen Dong, Qing Deng, Jian Liu, Tao Wen, Wei Han
-
Radiotherapy and Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC): Emerging Synergies and Unresolved Questions
Publication date: Available online 24 October 2026 Source: Cancer Pathogenesis and Therapy Author(s): Xingyuan Cheng, Yilu Gao, Mian Xi
-
Kirsten rat sarcoma viral oncogene (KRAS)-targeted therapy across cancer types: Context, resistance, and future directions
Publication date: Available online 24 October 2026 Source: Cancer Pathogenesis and Therapy Author(s): Yunxin Liu, Mengzhao Wang
-
Bridging the Diagnostic Gap in TP53-Mutated Myeloid Neoplasms: From Classification Discrepancies to a Practical cnLOH-Inclusive Diagnostic Framework
Publication date: Available online 29 October 2026 Source: Cancer Pathogenesis and Therapy Author(s): Yao Sun, Daihong Liu, Liping Dou, Liangding Hu
-
Locoregional-systemic combination therapy reshapes the treatment landscape of intermediate and advanced hepatocellular carcinoma (HCC)
Publication date: November 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 6 Author(s): Ying Zhu, Lunxiu Qin
-
Cancer-associated critical illness: A paradigm for sharp-phenotype critical illness
Publication date: November 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 6 Author(s): Shiyi Gong, Xiaoting Wang
-
Targeting minimal residual disease (MRD) in colorectal cancer: Therapeutic strategies, clinical trials, and the path toward molecular cure
Publication date: November 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 6 Author(s): Yusuf Saleem Khan, Aisha Farhana, Hatim Adam Nagi, Alfatih Mohamed Ahmed Alnajib, Tarig Ginawi, Abuzar Abdulwahab Osman, Abdullah...